Join to View Full Profile
515 Fairchild CtWoodland, CA 95695
Phone+1 530-668-2600
Fax+1 530-669-3661
Dr. Ghafouri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2017 - 2019
George Washington University School of Medicine and Health SciencesClass of 2016
Certifications & Licensure
CA State Medical License 2018 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 28 citationsCD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma.Sarah M Larson, Christopher M Walthers, Brenda Ji, Sanaz N Ghafouri, Jacob Naparstek
Cancer Discovery. 2023-03-01 - 2 citationsChemotherapy regimen choice and patient outcomes in early-stage triple-negative breast cancer: a retrospective analysis.Sanaz N Ghafouri, Rebecca W Nayeri, Nicholas P McAndrew, Sara A Hurvitz
Therapeutic Advances in Medical Oncology. 2022-01-01 - 15 citationsReal-World Experience of Axicabtagene Ciloleucel and Tisagenlecleucel for Relapsed or Refractory Aggressive B-cell Lymphomas: A Single-Institution Experience.Sanaz Ghafouri, Kathleen Fenerty, Gary J. Schiller, Sven de Vos, Herbert Eradat
Clinical Lymphoma, Myeloma & Leukemia. 2021-07-19
Press Mentions
Evaluating a New Bispecific CAR T-cell Therapy for B-cell LymphomasMay 1st, 2021- New CAR T Approach Minimizes Resistance, Helps Avoid Relapse in Non-Hodgkin's B-cell LymphomaApril 10th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
